Clinical Trial Update: SPC3649 Multiple Dose Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 multiple-dose study of SPC3649 in healthy volunteers was completed, examining safety and pharmacokinetics for Hepatitis C therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SPC3649

Snippet

Sponsor: Santaris Pharma A/S | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED